| 摘要 |
ATG-1622 polypeptides and polynucleotides and methods for producing such polypep tides by recombinant techniques are disclosed. Also disclosed are methods for utilizing A TG-1622 polypeptides and polynucleotides in the design of protocols for the treatment of heart diseas e, hypertension, kidney diseases, obesity, insulin resistance, lipodystrophy, diabetes, and CNS diseases , among others, and diagnostic assays for such conditions.
|
